The Hidden Gaps: Unveiling the Impact of Overlooked Women’s Health in Clinical Practice

Executive Summary

While there is growing recognition of the importance of integrating sex and gender considerations into healthcare, the practical challenges faced by physicians remain largely overlooked. From the physician's perspective, the lack of clear guidelines and tools manifests in their day-to-day patient interactions, creating significant hurdles: physicians are expected to deliver equitable, personalized care in a system that lacks the data and protocols necessary to address the distinct health needs of women.

This report explores the practical realities physicians face in the absence of sex-specific clinical data and guidelines, documenting their challenges, needs, and perspectives.

Methodology

Physician responses were collected via an online questionnaire that included 200 physicians from diverse practice settings across specialties: oncology, ophthalmology, endocrinology, cardiology, and neurology. Countries represented include the USA, Germany, Brazil, Thailand, Egypt, and Morocco.

The Physician's Perspective: Gaps That Undermine Women's Health

• 53% of responding physicians cited insufficient sex and gender-specific research and treatment guidelines as a major concern.
• 47% acknowledged that systemic biases, including unconscious gender stereotypes, undermine the quality of care.
• 80% of physicians observe sex differences in disease progression and treatment response, yet less than 30% feel equipped with resources to address them.

Specialty-Specific Findings

Oncology

Women face a 34% higher risk of severe side effects compared to men (Winstead, 2022). 90% of men vs 10% of women were asked about their sexual health during cancer care. 60% of U.S. oncologists reported that current research heavily influences their clinical practices, yet 30% frequently encounter cases where insufficient research creates barriers to care.

Endocrinology

90% of respondents identified research gaps as having a moderate to significant impact on patient outcomes. PCOS was identified as a top research priority by every surveyed endocrinologist. Thyroid dysfunction and Osteoporosis also highlighted as areas needing sex-specific focus.

Cardiology

CVD is the leading cause of death among women. Heart attacks in women often present with atypical symptoms (nausea, fatigue) leading to misdiagnosis. 77% of cardiologists report challenges in adapting male-centric protocols. Stroke and Hypertension emerged as priorities for sex-specific research.

Neurology

Women experience migraines three times more often than men. 90% of surveyed physicians identified migraines as a critical concern. Multiple Sclerosis (MS) and Alzheimer’s also disproportionately affect women and require life-stage specific management (pregnancy, menopause).

Ophthalmology

75% of ophthalmologists believe hormonal changes significantly affect women’s retinal health. AMD and diabetic retinopathy were prioritized for research. Women are more prone to dry eye disease and AMD.

In Conclusion

The barriers to equitable healthcare for women manifest differently across geographies but share a common need for sex-specific research and treatment guidelines. Physicians are ready for change, but require systemic reforms, better data collection, and actionable protocols.

Business Implications: Why This Matters for Employers, Insurers, and Policymakers

The gaps in women's health are not just clinical issues; they are economic and operational imperatives for businesses and health systems.

For Employers

• Productivity Loss: Unaddressed health issues like migraines, endometriosis, and menopause symptoms lead to significant presenteeism and absenteeism.
• Retention: Women are a large part of the workforce. Supporting their unique health needs through comprehensive benefits improves retention and loyalty.
• ROI: Investing in women's health yields high returns by keeping the workforce healthy and productive.

For Insurers & Payers

• Cost Containment: Misdiagnosis and delayed treatment (e.g., in cardiac care or autoimmune diseases) lead to more severe conditions and expensive emergency interventions later.
• Efficiency: Sex-specific protocols prevent adverse drug reactions (women are 1.5-2x more likely to experience them), reducing hospitalization costs.
• Value-Based Care: True value-based care cannot exist without accounting for 51% of the population's specific biological needs.

For Policymakers

• Economic Growth: Healthy women drive economic growth. Reducing the "health gap" could boost the global economy by $1 trillion annually (McKinsey, 2024).
• Public Health: Addressing sex-specific risk factors (like stroke risks in pregnancy) prevents long-term burden on public health systems.